Aclarion raises ~$2.5M via registered direct offering of stock and pre-funded warrants

Aclarion, Inc.

Issued 64,000 common shares and 236,000 pre-funded warrants at $8.36/share; gross proceeds ~$2.5M.
Pre-funded warrants have $0.00001 exercise price, exercisable immediately until fully exercised.
Proceeds to fund market development, The Clarity Trial, product development, and general corporate purposes.
Offering expected to close on October 14, 2025; placement agent fee is 7.0% of gross proceeds.
Dawson James Securities acts as exclusive placement agent for the offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.